期刊文献+

利用秀丽隐杆线虫构建抗菌物质体内筛选模型 被引量:3

Establishment of an Antibiotic Screening Model UsingCaenorhabditis elegans
下载PDF
导出
摘要 以秀丽隐杆线虫为模式生物,建立抗菌物质活体筛选模型.以铜绿假单孢菌感染线虫后,加入不同剂量已知抗生素治疗,观察线虫存活情况及体内细菌数量变化,确定模型建立的操作条件.结果表明,线虫感染程度可量化操作,最佳操作参数为:铜绿假单胞菌培养时间10~12 h,菌液浓度A600值1.0~1.2,线虫感染时间15 h.抗生素的使用能够显著提高感染线虫存活状况,其中环丙沙星治疗浓度范围为0~20μg/mL,线虫存活率和药物剂量之间具有稳定的线性关系. Caenorhabditis elegans are used to establish screening model for antimicrobial substances. C. elegans are infected with Pseudomonas aeruginosa, and then treated by different doses of known antibiotic. The survival rate of nematodes and the number of in vivo bacterial are observed, the operating conditions of the model establishment are determined. The results show that the operation of nematodes infection degree can be quantified. The optimal oper- ating parameters are as follows : pseudomonas aeruginosa training time 10 - 12 h, bacterium concentration Am 1.0 - 1.2 and infection time 15 h. Antibiotics can significantly prolong the life span of C. elegans. , and the effect of ciprofloxacin treatment indicates that there is stable linear relationship between survival rates of nematodes and antibiotics dose in concentration range of 0 -20 μg/mL.
出处 《烟台大学学报(自然科学与工程版)》 CAS 2012年第2期117-121,共5页 Journal of Yantai University(Natural Science and Engineering Edition)
基金 山东省自然科学基金资助项目(Y2008B21)
关键词 秀丽隐杆线虫 抗菌 筛选模型 Caenorhabditis elegans antibiotic screening model
  • 相关文献

参考文献10

  • 1杨再昌,杨小生.秀丽隐杆线虫(Caenorhabditis elegans)在药物筛选中的应用[J].生命科学,2009,21(4):593-598. 被引量:15
  • 2Ausubel F M. Are innate immune signaling pathways in plants and animals conserved[J].Nature Immunology,2005,(06):973-979. 被引量:1
  • 3Kim D H,Ausubel F M. Evolutionary perspectives on innate immunity from the study of Caenorhabditis elegans[J].Current Opinion in Immunology,2005,(01):4-10.doi:10.1016/j.coi.2004.11.007. 被引量:1
  • 4Lai Chunhung,Chou Changyuan,Chang Lanyang. Identification of novel human genes evolutionarily conversed in Caenorhabditis elegans by comparative proteomics[J].Genome Research,2000,(5):703-713.doi:10.1101/gr.10.5.703. 被引量:1
  • 5Moy T I,Ball A R,Ausubel F M. Identification of novel antimicrobials using a live-animal infection model[J].Proceedings of the National Academy of Sciences(USA),2006,(27):10414-10419.doi:10.1073/pnas.0604055103. 被引量:1
  • 6Breger J,Fuchs B B,Aperis G. Antifungal chemical compounds identified using a C.elegans pathogenicity assay[J].PLoS Pathogens,2007,(02):168-178.doi:10.1371/journal.ppat.0030018. 被引量:1
  • 7杨再昌,马小彦,乐意,牛玉乐,乔冲.用秀丽隐杆线虫观察43种中药的体内抗菌药效[J].时珍国医国药,2010,21(5):1174-1175. 被引量:18
  • 8Brenner S. The genetics of Caenorhabditis elegans[J].Genetics,1974.71-94. 被引量:1
  • 9Jonathan J E. Tackling both sides of the host-pathogen equation with Caenorhabditis elegans[J].Microbes and Infection,2002,(04):247-256. 被引量:1
  • 10Man-Mah T,Shalina M M,Ausubel F M. Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis[J].Proceedings of the National Academy of Sciences(USA),1999.715-720. 被引量:1

二级参考文献26

  • 1谢存柱.柴胡白虎汤治疗急性化脓性扁桃腺炎[J].云南中医杂志,1993,14(6):16-16. 被引量:1
  • 2Olsen A, Vantipalli MC, Lithgow GJ. Using Caenorhabditis elegans as a model for aging and age-related diseases. Ann NY Acad Sci, 2006, (5): 120-8. 被引量:1
  • 3Evason K, Huang C, Yamben I, et al. Anticonvulsant medications extend worm life-span. Science, 2005, 307 (12): 258- 62. 被引量:1
  • 4Petrascheck M, Ye XL, Buck LB. An antidepressant that extends lifespan in adult Caenorhabditis elegans. Nature, 2007, 450 (11): 553-6. 被引量:1
  • 5Gerisch B, Rottiers V, Li D, et al. A bile acid-like steroid modulates Caenorhabditis elegans lifespan through nuclear receptor signaling. Proc Natl Acad Sci USA, 2007, 104 (12):5014-9. 被引量:1
  • 6Viswanathan M, Kim SK, Berdichevsky A, et al. A role for SIR-2.1 regulation of ER stress response genes in determining C.elegans lifespan. Dev Cell, 2005, 9 (5): 605-15. 被引量:1
  • 7Sdvastava D, Arya U, Soundara Rajan T, et al. Reserpine can confer stress tolerance and lifespan extension in the nematode C.elegans. Biogerontology, 2008, 9 (5): 309-16. 被引量:1
  • 8Collins JJ, Evason K, Komfeld K. Pharmacology of delayed aging and extended lifespan of Caenorhabditis elegans. Exp Gerontol, 2006,41 (10): 1032-9. 被引量:1
  • 9Kaletta T, Hengartner MO. Finding function in novel targets: C. elegans as a model organism. Nat Rev Drug Discov, 2006, 5 (5): 387-98. 被引量:1
  • 10Bhavsar AP, Brown ED.The worm turns for antimicrobial discovery. Nat Biotechnol, 2006, 24 (9): 1098-100. 被引量:1

共引文献31

同被引文献16

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部